- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
PARTICULARS AND SUMMARIES WHICH ARE TO ACCOMPANY A NOTICE GIVEN OR SENT UNDER ARTICLE 4(1)(a)
4.The chemical structural formula for each active constituent or, where...
5.A description of the pharmaceutical form in which the medicinal...
6.The specification of the medicinal product including a statement of...
8.A description of the containers used for the medicinal product...
9.The proposed dosage and its duration, and the methods and...
10.A description of the proposed clinical trial including the duration...
11.(a) A summary of pharmaceutical data in respect of the...
12.(a) Where a specification has been established for a constituent—...
14.Summaries of reports and evaluations of any experimental and biological...
MATTERS IN RESPECT OF WHICH THE LICENSING AUTHORITY SHALL FORTHWITH BE INFORMED OF CHANGES
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include: